AD
Ayala Pharmaceuticals, Inc.
ADXS · OTC
$0.60 +0.00% (+$0.00)
Market Cap $6.31M
P/E Ratio 0.26x
Div. Yield -
ROE -
Analýza
AI report o byznysu, financích, ocenění, sentimentu, zprávách a rizicích - napsaný během několika minut.
Piotroski F-Score Weak
1/9Valuation
72 /100
Cheap P/E 0.26x
EV/EBITDA 2.96x
P/S 0.09x
Growth
4 /100
Declining Rev. growth 9.81%
Book val. growth 1.03%
EPS growth N/A
Profitability
57 /100
Moderate Gross margin 94.85%
Net margin 17.63%
Op. margin 59.47%
Quality
14 /100
Poor ROIC 33.02%
ROA 4.48%
Asset turnover 0.25x
Debt
45 /100
Moderate Debt/Equity 1.50x
Current ratio 3.91x
Int. coverage 1.26x
Stability
45 /100
Moderate Beta -4.03x
Rev. volatility 10.59%
EPS volatility 6,761.11%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ADXS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kenneth A. Berlin
Employees
20
Headquarters
Monmouth Junction